AMSBIO has introduced a range of purified cancer exosome samples to help researchers study the role of exosomes in cancer development and metastasis.

By targeted filtration of patient serum using a specific binding method removes protein contaminant to isolate exosome at 95% high purity. Using this proprietary filtration method, the purified tumor exosome does not contain any polymer or detergent (SDS, NP-40 or Triton). The purified tumor exosome can be used for RNA or protein analysis techniques such as qRT-PCR, microarray and mass spectrometry. AMSBIO also offer purified tumor exosomal RNA that is ready-to-use for Next Generation Sequencing.

The AMSBIO purified tumor exosome range include samples from bladder, breast, colorectal, Crohn’s disease, diabetes type 1, kidney, leukemia, liver, melanoma, nasopharyngeal, non-Hodgkin lymphoma, prostate, psoriasis, rheumatoid arthritis, systemic lupus, thyroid and uterine corpus cancers. This product range is for research use only.

Exosomes are small endosome derived lipid nanoparticles actively secreted by exocytosis in most living cells. Release of exosomes occurs either constitutively or upon induction, under both normal and pathological conditions, in a dynamic, regulated and functionally relevant manner. Isolated from diverse cell lines, Exosomes have been shown to have pleiotropic physiological and pathological functions and play significant roles in diverse pathological conditions such as cancer, infectious and neurodegenerative diseases.

For further information on the new range of purified cancer exosome samples please visit www.amsbio.com/exosomes.aspx  or contact AMSBIO on +44-1235-828200/ +1-617-945-5033 / [email protected] .

AMSBIO offer a wide selection of new high quality products for exosome research. Formulated to be quick, affordable and easy to use, AMSBIO’s suite of quantification kits, isolation tools, standards, DNA & RNA extraction kits, antibodies and cell culture reagents will facilitate your understanding of exosomes using a wide variety of samples.

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO can draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective.